Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:41 AM
Ignite Modification Date:
2025-12-25 @ 12:41 AM
NCT ID:
NCT03241667
Eligibility Criteria:
Inclusion Criteria:
* 18-75 y/o
* ESRD on hemodialysis for at least 3 months
* HD access capable of sustaining at least 300 ml/min blood flow
* Hg \> 10.0 g
* Able to take aspirin 81 mg/day for a week prior to the study (for those subjects not already on aspirin)
* Able to read, speak and understand English
* Capable of providing signed informed consent
* HD pt at one of the UCSF outpatient HD units
Exclusion Criteria:
* Subjects with active liver, cardiovascular, neurologic or psychiatric diseases
* Subjects with other active medical problems (e.g., cancer undergoing treatment)
* h/o intradialytic or orthostatic hypotension
* h/o thrombosis or on treatment for thrombosis or use of anticoagulants, excluding antiplatelet agents
* h/o active infection or on antibiotics
* h/o active autoimmune diseases or other inflammatory states
* Ongoing alcohol or illegal drug use
* Pregnant
* H/o hemolysis or allergic reactions to any dialyzers
* Anyone who in the opinion of the study doctors is not qualified to be in the study.
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT03241667
Study Brief:
Protocol Section:
NCT03241667